Reuters logo
BRIEF-Bayer submits U.S. license application for Hemophilia treatment
August 31, 2017 / 5:32 AM / 23 days ago

BRIEF-Bayer submits U.S. license application for Hemophilia treatment

Aug 31 (Reuters) - Bayer AG

* Says submits biologics license application in U.S. for BAY94-9027 Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below